Enquiry/Quote

Critical Care

Trusted pharma products in Critical Care

Noradrenaline Bitartrate

Strength: 2 mg / mL, 1mg/ml, 0.08 mg/mL

Form: Injection / infusion

Reference Brands: Levophed (USA)

View Details Get Enquiry

Norepinephrine

Strength: 1 mg/mL (0.1%), 2 mg/mL, 4 mg/mL

Form: Injection/Concentrate for IV infusion (Must be diluted before use)

Reference Brands: Levophed®(US), Norad™(India),

View Details Get Enquiry

Normal Saline

Strength: 0.9% w/v (9 mg/mL sodium chloride)

Form: Intravenous (IV) Infusion Solutions

Reference Brands: Normal Saline(Generics)

View Details Get Enquiry

Obeticholic acid

Strength: 5 mg, 10 mg

Form: Tablets

Reference Brands: Ocaliva (USA)

View Details Get Enquiry

Oleoylethanolamide,Valine and Vitamin-E Capsules

Strength: 215mg

Form: Capsules

Reference Brands:

View Details Get Enquiry

Omega 3 Fatty Acids With Vitamin E

Strength: Fatty Acids:-300mg Vitamin-E:-100 I.U.

Form: Capsules

Reference Brands:

View Details Get Enquiry

Osilodrostat

Strength: 1mg, 5mg, 10mg

Form: Tablets

Reference Brands: Isturisa (USA/EU)

View Details Get Enquiry

Pentamidine Isethionate

Strength: 300 mg

Form: Injection / Inhalation solution

Reference Brands: Pentam (USA), Nebupent (USA)

View Details Get Enquiry

Pentobarbital sodium

Strength: 50 mg, 100 mg , 15 mg/mL, 25 mg/mL, 50 mg/mL, 65 mg/mL

Form: Tablets / Oral solution / Injection

Reference Brands: Nembutal (USA)

View Details Get Enquiry

Phenylephrine

Strength: 10 mg/mL

Form: Injection (IV)

Reference Brands: Neo-Synephrine®, Biorphen®(US); Phenylephrine, Metaoxedrine®(EU)

View Details Get Enquiry

Piperacillin / Tazobactam Intravenous (IV) Injection/Infusion

Strength: 2.25 g (2 g Piperacillin + 0.25 g Tazobactam); 3.375 g(3+3.75g); 4.5g(4+0.5g)

Form: Intravenous (IV) Injection/Infusion

Reference Brands: Zosyn(US); Tazocin(EU)

View Details Get Enquiry

Plerixafor

Strength: 20 mg/mL

Form: Injection

Reference Brands: Mozobil (USA/EU)

View Details Get Enquiry

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.